Skip to main content
Article
Treatment of Paralysis Caused by West Nile Virus in Hamsters
Antiviral Research
  • John D. Morrey, Utah State University
  • V. Siddharthan
  • H. Wang
  • Aaron L Olsen, Utah State University
  • Ramona T. Skirpstunas, Utah State University
  • Jeffery O. Hall, Utah State University
  • H. Li
  • S. Koenig
  • S. Johnson
  • J. L. Nordstrom
  • N. Marlenee
  • R. A. Bowen
  • M. S. Diamond
Document Type
Article
Publisher
Elsevier
Publication Date
1-1-2007
DOI
10.1016/j.antiviral.2007.01.022
Disciplines
Abstract
WNV-specific humanized monoclonal antibody (hE16) was used to treat WNV-induced poliomyelitis and fatal WNV-aerosolization when administered as a single intraperitoneal (i.p.) injection days after the virus had infected the spinal cord of rodents.
Comments
Originally published by Elsevier. Publisher's PDF and HTML fulltext available through remote link.
Citation Information
Morrey, J.D., V. Siddharthan, H. Wang, A.L. Olsen, R. Skirpstunas, J. O. Hall, H. Li, S. Koenig, S. Johnson, J. L. Nordstrom, N. Marlenee, R. A. Bowen and M.S. Diamond 2007. Treatment of Paralysis Caused by West Nile Virus in Hamsters. Antiviral Research, 74 (3): A32.